Clinical trial
A Prospective Multicenter Trial To Evaluate The Safety And Effectiveness Of The MEL 80 Excimer Laser Using LASIK (Laser In Situ Keratomileusis) For The Correction Of > -7.00 D to -12.00 D Of Myopia With Up To -6.00 D Of Astigmatism, and Maximum MRSE of ≤ -12.00 D
NCT00762541 is registered in ClinicalTrials.gov with Carl Zeiss Meditec, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multicenter Trial To Evaluate The Safety And Effectiveness Of The MEL 80 Excimer Laser Using LASIK (Laser In Situ Keratomileusis) For The Correction Of > -7.00 D to -12.00 D Of Myopia With Up To -6.00 D Of Astigmatism, and Maximum MRSE of ≤ -12.00 D
- Lead sponsor
- Carl Zeiss Meditec, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2006
- Completion date
- July 31, 2009
- Enrollment
- 129 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.